The Brazilian Instituto nacional da Propriedade Industrial announced it will fast track its decision on whether or not to grant patents on the heat-stablized versions of lopinavir+ritonavir (brand names: Kaletra, Aluvia) and ritonavir (Norvir). Both drugs are important antiretroviral drugs…